From the pinnacles of power by Fortune editor at large Patricia Sellers
Type Size  -  +
June 23, 2008, 6:26 pm

Pfizer Pfizzle

It’s remarkable to see Pfizer (PFE) stock trading below 18. That’s a price level unseen since 1997. When CEO Jeff Kindler (formerly of McDonalds (MCD)) came by Fortune recently, he fielded questions about the business’ well-known challenges: expiring patents, pipeline deficiencies, slow new-product approvals. He talked about his game plan, but one statistic conveys why his entire industry is suffering: Pharma revenues rose only 3.8 percent in 2007. This is the lowest growth rate since 1961. The stat reminded my Fortune colleagues of a 1991 cover story called America’s Most Profitable Business. That story says that in the 30 years before 1991, Fortune 500 drug-makers grew briskly and enjoyed the fattest profits in big business.

Those were the days. A March 2008 report by IMS Health predicts no relief from the slow growth. For one thing, Lipid regulators (such as Pfizer’s blockbuster cholesterol fighter, Lipitor), is the largest therapy class in the U.S., but sales are declining. Even more grim, the report says that last year new product launches in the pharma industry were at their lowest level in three decades. – Jessica Shambora

Next: Where the pharma industry is healthy

Look, the pleasure receptors in your brain are no different than mine. Find someone who is taking Chantix, take one, just one. You might be okay, or you might want to claw your face off…literally. Just as important, if you smoke, keep trying to quit, by any means necessary. Thanks for your time

Posted By James, Plainfield IN : June 25, 2008 12:47 pm

James,

You are about as uninformed on a topic as one can be. To suggest that Chantix has had more problems than anything else out there is insane. There is always a risk/benefit with every drug and it so happens that Chantix targets the addiction that causes more harm than anything else.

Do some research before you make these claims, I can name 5 drugs that provide less benefit to reducing chronic illness that have more serious side effects.

Get a clue.

Posted By Matt, Minneapolis : June 25, 2008 10:04 am

Hey James,
when it comes to the stock market, it all about the money and only when you feed (revenue) the wall street machine does it love you. There are many things more important than making money: you family, life, etc but business is busines….You make it sound as if Pfizer should be a benevolent charity….that is not their model…they are “for profit”.

Posted By Dave in Ann Arbor, MI : June 24, 2008 3:00 pm

I am a former PFE employee and current stockholder. Pfizer was a great company to work for, the employees were always considered their most valuable asset, I hope they are still maintaining that perspective in these unsettling times. There was a time when the CEO knew everyone in the original Brooklyn plant by their first names, I think I’ll buy some more stock now at these prices.

Posted By Bill McMahon, Bethpage, NY : June 24, 2008 1:04 pm

So far, pilots, air traffic controllers, crane operators, train operators, bus drivers, and truck drivers can not be medically certified if they use Chantix. There will be more restrictions on it’s use in coming months. To say that this will not affect Pfizer’s stock is not based in reality. I think that everybody should quit smoking, but Chantix is not the way to do it.

Posted By James, Plainfield IN : June 24, 2008 11:58 am

ASk them why they have a former macdonalds executive running a pharmaceutical company. At some point that business is about science.

Posted By Stan Davis Spokane, wa : June 24, 2008 10:14 am

first off, learn proper grammar before making posts. sometimes there ARE not is. then try to understand the difference between a stock and the company. Pfizer does not make money from the stock market, they make money by selling drugs. You speak of chantix, do you know what the drug is for? Smoking cessation. So are you saying it is better for people to continue to smoke? And more importantly, with regards to problems with drugs, I want you to name a drug that carries with it no side effects. Such a drug does not exist. Every drug, including an antibiotic, tylenol or even OTC supplements caries some risk of harm. NOTHING is side effect free and 100% safe. Pfizer problem is that wall street is short sighted and no analysts are willing to tell their clients to commit their money to it. why, because it isnt growing fast enough. 3% growth on 10 billion dollars is still 300 million dollars which is a hell of a lot more money than some of these small cap agro and energy companies make. But, wall street is so fixated on percentages and growth rates rather than actual money. Maybe these stupidalysts shoud listen to Tom Cruise in JM, when he said, “SHOW ME THE MONEY!!!”

Posted By Sam, Plainview, NY : June 24, 2008 10:10 am

Chantix is great medicine. The ‘independent’ study that made Chantix look so bad was done at Wake Forest University which sits on property donated by R.J. Reynolds. Get the picture?

Posted By chuck D. Tustin CA : June 24, 2008 9:51 am

I think that part of PFE’s decline can be attributed to problems with Chantix. I can not think of any other medicine with the amount of problems that this medicine has. I believe that there will be more problems with this drug that have not been fully realized yet. I feel that Pfizer should recall this medicine, take it’s losses and move on. Sometimes there is more important things that just making money in the stock market.

Posted By James, Plainfield IN : June 24, 2008 9:28 am
CNNMoney.com Comment Policy: CNNMoney.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene, pornographic or other material that would violate the law. Please note that CNNMoney.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors and commenters. By submitting your comment, you hereby give CNNMoney.com the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now known or hereafter devised, worldwide, in perpetuity. CNNMoney.com Privacy Statement.
Sheryl Sandberg Sheryl Sandberg: Don't leave before you leave
COO of Facebook
Marlo Thomas Marlo Thomas: Why she gives to kids in need
National outreach director, St. Jude Children's Research Hospital
Carol Bartz Carol Bartz: Just deal with it!
CEO of Yahoo
From CEO to candidateFormer eBay boss Meg Whitman talks about her plans for California. Watch
Paula Deen's American dreamRestaurant entrepreneur and Food Network star shares her life story. Watch
Pattie SellersPatricia Sellers has written some of Fortune's most talked-about cover stories, including "Can Meg Whitman Save California?", Melinda Gates ("The $100 Billion Woman"), "MySpace Cowboys," Martha Stewart ("I cannot be destroyed"), Ted Turner ("Gone with the Wind") and Oprah Winfrey ("Oprah Inc."). And she has broken ground with insightful pieces on career management issues such as ego ("Get Over Yourself!"), and "Charisma: Do You Need It? Can You Get It?" Pattie chairs the annual Fortune Most Powerful Women Summit, the preeminent gathering of women leaders in business, philanthropy, government, academia, and the arts. And she has helped oversee Fortune's "Most Powerful Women in Business" cover package since its launch in 1998. She started at Fortune in 1984, covering the big consumer brand companies.
Subscribe to Postcards: RSS feed | email newsletter

Every year Fortune and the U.S. State Department sponsor the Global Women Leaders Mentoring Partnership, which brings rising-star women from developing countries to the U.S. to work closely with participants of the annual Fortune Most Powerful Women Summit - among them CEOs Andrea Jung of Avon, Ann Moore of Time Inc., and Ursula Burns of Xerox.
* : Time reflects local markets trading time.† - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges.• Disclaimer
Powered by WordPress.com VIP.